Why the study?
Does the LACE index predict 30-day and 90-day readmission or death in an older Portuguese population?
Does the LACE index predict 30-day and 90-day readmission or death in an older Portuguese population?
The LACE index has poor discriminative ability for predicting 30- and 90-day readmission or death in complex elderly medical patients and should be used with reservations.
Answers are grounded in this paper and cite their sources.
LACE index warrants cautious use for readmission or death prediction in older adults; leaves open its broader utility pending prospective validation.
<ns4:p> <ns4:bold>Background:</ns4:bold> Unplanned readmissions are frequent, associated with high costs and potentially preventable. Pre-discharge risk screening is a crucial step to prevent hospital readmissions. This study evaluates the LACE index as a tool capable of identifying patients with high risk of early readmission or death in an older Portuguese population. </ns4:p> <ns4:p> <ns4:bold>Methods:</ns4:bold> We performed a retrospective study in a tertiary care hospital in Portugal. All acute patients, aged ≥ 65 years, discharged from the Internal Medicine Service between 1 January and 30 June 2014 were included. Data was collected from hospital records. The LACE index was calculated for each patient. A comparative analysis was performed based on a cutoff of 10 (≥10 indicates a high-risk population) for the LACE score. </ns4:p> <ns4:p> <ns4:bold>Results:</ns4:bold> 1407 patients were evaluated, with a mean age of 81.7±7.6 years; 41.2% were male, 52.2% were dependent for ≥1 activities of daily living, the average Charlson comorbidity index was 3.54±2.8. There were 236 (16.8%) readmissions, 132 (9.4%) deaths and 307 (21.8%) patients were dead and/or readmitted within 30 days of discharge. At 90 days, 523 (37.2%) patients were dead and/or readmitted. The LACE score was higher in patients who died or were readmitted within 30 days compared with those who were not (13.2±2.7 versus 11.5±3.0, <ns4:italic>p</ns4:italic> <0.0001). Patients with LACE score ≥10 had significantly higher mortality and readmission rates compared to those with LACE score <10: at 30 days, 25.5% versus 9.3% (OR 3.34, 95% CI 2.24-4.98, <ns4:italic>p <0.0001</ns4:italic> ); at 90 days, 43.4% versus 16.2% (OR 3.98, 95% CI 2.89-5.49, <ns4:italic>p <0.0001</ns4:italic> ). However, the discriminative capacity of LACE index assessed by C-statistic was relatively poor: 0.663 (95% CI 0.630-0.696) and 0.676 (95% CI 0.648-0.704), respectively. </ns4:p> <ns4:p> <ns4:bold>Conclusions:</ns4:bold> This study shows that the LACE index should be used with reservations for predicting 30 and 90-day readmission or death in complex elderly patients. </ns4:p>
No takes yet. Share an insight, caveat, or question.
Fonseca et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: